Bionano Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.99	9.17	17.95	5.09	24.57
Short-Term Investments	16.28	0.3	48.82	108.1	226.04
Cash & Short-Term Investments	19.27	9.48	66.77	113.19	250.61
Cash Growth	103.37%	-85.81%	-41.01%	-54.84%	551.80%
Accounts Receivable	5.2	4.75	9.32	7.02	4.93
Inventory	5.45	11.12	22.89	29.76	12.39
Other Current Assets	15.47	14.14	41.14	7.33	4.48
Total Current Assets	45.39	39.49	140.12	157.3	272.41
Net Property, Plant & Equipment	21.16	24.32	32.48	28.96	37.46
Other Intangible Assets	4.35	9.71	33.97	41.14	56.16
Goodwill	-	-	-	77.29	0.75
Other Long-Term Assets	2.69	3.15	7.83	2.81	11.07
Total Assets	73.58	76.67	214.4	307.5	377.1
Accounts Payable	5.59	6.96	10.38	12.53	10.77
Accrued Expenses	5.46	5.64	8.09	10.55	8.62
Short-Term Debt	9.98	20.36	69.8	-	-
Current Portion of Leases	0.95	3.25	2.44	2.55	1.77
Unearned Revenue	0.97	1.13	0.78	0.87	0.68
Other Current Liabilities	-	-	8.53	9.38	-
Total Current Liabilities	22.94	37.34	100.03	35.88	21.84
Long-Term Leases	5.97	3.68	7.18	9.12	8.93
Other Long-Term Liabilities	0.25	0.27	11.04	13.1	9.21
Total Long-Term Liabilities	6.22	3.95	18.22	22.22	18.14
Total Liabilities	29.16	41.3	118.25	58.1	39.98
Common Stock	0	-	-	0	0.03
Additional Paid-in Capital	764.03	728.57	677.34	599.23	553.75
Accumulated Other Comprehensive Income	0.02	0.03	0.02	-1.12	-0.54
Retained Earnings	-719.62	-693.23	-581.21	-348.72	-216.12
Shareholders' Equity	44.42	35.38	96.16	249.4	337.12
Total Liabilities & Equity	73.58	76.67	214.4	307.5	377.1
Total Debt	16.89	27.3	79.41	11.67	10.7
Net Cash (Debt)	2.38	-17.82	-12.64	101.52	239.92
Net Cash Growth	-	-	-	-57.69%	984.42%
Net Cash Per Share	0.44	-14.02	-22.22	210.61	520.08
Book Value	44.42	35.38	96.16	249.4	337.12
Book Value Per Share	8.16	27.83	168.99	517.41	730.79
Tangible Book Value	40.08	25.67	62.18	130.97	280.21
Tangible Book Value Per Share	7.36	20.20	109.28	271.70	607.43

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q